Pre-Open Stock Movers 11/5: (BIGC) (EXPE) (PFE) Higher; (PTON) (MRNA) (MRK) Lower (more...)
Pre-Open Stock Movers:
Peloton (NASDAQ: PTON) 33% LOWER; reported Q1 EPS of ($1.25), $0.18 worse than the analyst estimate of ($1.07). Revenue for the quarter came in at $805.2 million versus the consensus estimate of $810.76 million. Peloton sees Q2 2022 revenue of $1.1-1.2 billion, versus the consensus of $1.51 billion. Peloton sees FY2022 revenue of $4.4-4.8 billion, versus the consensus of $5.4 billion.
Moderna, Inc. (NASDAQ: MRNA) 14.7% LOWER; falls on positive data from Pfizer's COVID-19 antiviral drug.
BigCommerce (NASDAQ: BIGC) 14.3% HIGHER; reported Q3 EPS of ($0.06), $0.08 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $59.3 million versus the consensus estimate of $54.84 million. BigCommerce sees Q4 2021 revenue of $61.3-61.7 million, versus the consensus of $60.9 million. BigCommerce sees FY2021 revenue of $216.2-216.6 million, versus the consensus of $211.36 million.
Expedia (NASDAQ: EXPE) 13.5% HIGHER; reported Q3 EPS of $3.53, $1.80 better than the analyst estimate of $1.73. Revenue for the quarter came in at $2.96 billion versus the consensus estimate of $2.76 billion.
Datadog, Inc. (NASDAQ: DDOG) 12.6% HIGHER; reported Q3 EPS of $0.13, $0.07 better than the analyst estimate of $0.06. Revenue for the quarter came in at $270 million versus the consensus estimate of $247.73 million. Datadog, Inc. sees Q4 2021 EPS of $0.11-$0.12, versus the consensus of $0.06. Datadog, Inc. sees Q4 2021 revenue of $290-292 million, versus the consensus of $263.3 million.
Bill.com (NYSE: BILL) 10.5% HIGHER; reported Q1 EPS of ($0.15), $0.06 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $116.4 million versus the consensus estimate of $103.41 million. Bill.com sees FY2022 EPS of ($0.80)-($0.77), versus the consensus of ($0.90). Bill.com sees FY2022 revenue of $538-541 million, versus the consensus of $487 million.
Merck & Co., Inc. (NYSE: MRK) 10% LOWER; falls on positive data from Pfizer's completing COVID-19 antiviral drug.
Pfizer Inc. (NYSE: PFE) 9.7% HIGHER; announced its investigational novel COVID-19 oral antiviral candidate, PAXLOVID™, significantly reduced hospitalization and death, based on an interim analysis of the Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) randomized, double-blind study of non-hospitalized adult patients with COVID-19, who are at high risk of progressing to severe illness. The scheduled interim analysis showed an 89% reduction in risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset (primary endpoint); 0.8% of patients who received PAXLOVID™ were hospitalized through Day 28 following randomization (3/389 hospitalized with no deaths), compared to 7.0% of patients who received placebo and were hospitalized or died (27/385 hospitalized with 7 subsequent deaths). The statistical significance of these results was high (p<0.0001). Similar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset; 1.0% of patients who received PAXLOVID™ were hospitalized through Day 28 following randomization (6/607 hospitalized, with no deaths), compared to 6.7% of patients who received a placebo (41/612 hospitalized with 10 subsequent deaths), with high statistical significance (p<0.0001). In the overall study population through Day 28, no deaths were reported in patients who received PAXLOVID™ as compared to 10 (1.6%) deaths in patients who received placebo
GoPro (NASDAQ: GPRO) 8.7% HIGHER; reported Q3 EPS of $0.34, $0.14 better than the analyst estimate of $0.20. Revenue for the quarter came in at $317 million versus the consensus estimate of $292.19 million.
Synaptics (NASDAQ: SYNA) 6.8% HIGHER; reported Q1 EPS of $2.68, $0.09 better than the analyst estimate of $2.59. Revenue for the quarter came in at $3.73 billion versus the consensus estimate of $370.63 million. Synaptics sees Q2 2022 revenue of $390-420 million.
Yelp (NYSE: YELP) 6.8% HIGHER; reported Q3 EPS of $0.23, $0.23 better than the analyst estimate of $0.00. Revenue for the quarter came in at $269.2 million versus the consensus estimate of $261.77 million. Yelp sees Q4 2021 revenue of $265-275 million, versus the consensus of $275.2 million.
Novavax (NASDAQ: NVAX) 6.7% HIGHER; reported Q3 EPS of ($4.31), $0.40 worse than the analyst estimate of ($3.91). Revenue for the quarter came in at $178.8 million versus the consensus estimate of $334.62 million.
Pinterest (NYSE: PINS) 6.5% HIGHER; reported Q3 EPS of $0.28, $0.05 better than the analyst estimate of $0.23. Revenue for the quarter came in at $633 million versus the consensus estimate of $631.24 million.
Square (NYSE: SQ) 4.7% LOWER; reported Q3 EPS of $0.37, $0.01 worse than the analyst estimate of $0.38. Revenue for the quarter came in at $3.84 billion versus the consensus estimate of $4.6 billion.
DraftKings (NASDAQ: DKNG) 4.5% LOWER; reported Q3 EPS of ($1.35), versus ($1.06) reported last year. Revenue for the quarter came in at $213 million versus the consensus estimate of $236.6 million. DraftKings sees FY2021 revenue of $1.24-1.28 billion, versus the consensus of $1.29 billion. DraftKings sees FY2022 revenue of $1.7-1.9 billion, versus the consensus of $1.81 billion.
Appian Corporation (NASDAQ: APPN) 4% LOWER; reported Q3 EPS of ($0.22), $0.03 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $92.42 million versus the consensus estimate of $91.1 million. Appian Corporation sees Q4 2021 EPS of ($0.24)-($0.21). Appian Corporation sees Q4 2021 revenue of $95-95.5 million.
Turtle Beach (NASDAQ: HEAR) 3.5% HIGHER; reported Q3 EPS of $0.14, $0.09 better than the analyst estimate of $0.05. Revenue for the quarter came in at $85.3 million versus the consensus estimate of $78.38 million. Turtle Beach sees FY2021 EPS of $1.10-$1.45. Turtle Beach sees FY2021 revenue of $365-380 million.
First Solar (NASDAQ: FSLR) 3.2% LOWER; reported Q3 EPS of $0.42, $0.17 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $584 million versus the consensus estimate of $684.96 million. First Solar maintains FY2021 EPS of $4.00-$4.60 and FY2021 revenue of $2.875-3.1 billion.
Citrix Systems (NASDAQ: CTXS) 2.5% LOWER; Morgan Stanley downgraded from Equalweight to Underweight with a price target of $85.00 (from $90.00).